S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund

Indiva Stock Price, News & Analysis (CVE:NDVA)

C$0.11
0.00 (0.00%)
(As of 12/5/2023 05:23 PM ET)
Compare
Today's Range
C$0.11
C$0.13
50-Day Range
C$0.04
C$0.11
52-Week Range
C$0.02
C$0.14
Volume
266,567 shs
Average Volume
193,101 shs
Market Capitalization
C$20.49 million
P/E Ratio
N/A
Dividend Yield
4.04%
Price Target
C$0.13

NDVA stock logo

About Indiva Stock (CVE:NDVA)

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.

NDVA Stock Price History

NDVA Stock News Headlines

The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
Indiva Ltd NDVA
Closing Bell: Indiva Ltd up on Monday (NDVA)
Indiva (OTC: NDVA.F)
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
Indiva Reports Second Quarter 2023 Results
Closing Bell: Indiva Ltd up on Tuesday (NDVA)
Indiva Launches No Future Gummies and Vapes
Indiva Reports First Quarter 2023 Results
Closing Bell: Indiva Ltd down on Friday (NDVA)
Indiva Reports Record Fiscal Year 2022 Results
See More Headlines
Receive NDVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indiva and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$0.13
High Stock Price Target
C$0.13
Low Stock Price Target
C$0.13
Potential Upside/Downside
+18.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
C$-6,940,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$36.01 million
Cash Flow
C$0.02 per share

Miscellaneous

Free Float
N/A
Market Cap
C$20.49 million
Optionable
Not Optionable
Beta
1.31
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Carmine Marotta
    Co-Founder, President, CEO & Director
  • Ms. Jennifer Welsh
    Chief Financial Officer
  • Mr. Robert William Carse
    Chief Operating Officer
  • Mr. Sung Kang
    Chief Commercial Officer
  • Mr. Pete Young
    Co-founder
  • Mark Haynes
    Vice President of Sales
  • Mr. Mitchell Stern
    Vice President of Marketing














NDVA Stock Analysis - Frequently Asked Questions

Should I buy or sell Indiva stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Indiva in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NDVA shares.
View NDVA analyst ratings
or view top-rated stocks.

What is Indiva's stock price target for 2024?

1 Wall Street analysts have issued 1-year target prices for Indiva's stock. Their NDVA share price targets range from C$0.13 to C$0.13. On average, they predict the company's stock price to reach C$0.13 in the next year. This suggests a possible upside of 18.2% from the stock's current price.
View analysts price targets for NDVA
or view top-rated stocks among Wall Street analysts.

How have NDVA shares performed in 2023?

Indiva's stock was trading at C$0.11 at the beginning of 2023. Since then, NDVA shares have increased by 4.8% and is now trading at C$0.11.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Indiva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Indiva investors own include Curaleaf (CURLF), Dynavax Technologies (DVAX), Heat Biologics (HTBX), Organigram (OGI), Vaxart (VXRT), Aurora Cannabis (ACB), Acasti Pharma (ACST), Allena Pharmaceuticals (ALNA) and Energy Transfer (ET).

How do I buy shares of Indiva?

Shares of NDVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:NDVA) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -